Chrissy Almond
Overview
Explore the profile of Chrissy Almond including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
8
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nilsson F, Asanin S, Masters E, Iadeluca L, Almond C, Cooper M, et al.
Pharmacoeconomics
. 2021 Jun;
39(8):941-952.
PMID: 34080140
Background: Lorlatinib is a third-generation anaplastic lymphoma kinase (ALK)/c-ros oncogene 1 (ROS1) tyrosine kinase inhibitor (TKI) with efficacy in patients with ALK-rearranged non-small-cell lung cancer (NSCLC) previously treated with a...
2.
McCarthy G, Fenu E, Bennett N, Almond C
Adv Ther
. 2019 Feb;
36(3):632-644.
PMID: 30726549
Introduction: This study sought to determine the cost-effectiveness of intravitreal ranibizumab compared with best supportive care (BSC; considered to be no active treatment) for the treatment of visual impairment due...
3.
Hansson-Hedblom A, Almond C, Borgstrom F, Sly I, Enkusson D, Troelsgaard Buchholt A, et al.
Cost Eff Resour Alloc
. 2018 Aug;
16:28.
PMID: 30123097
Background: Human monoclonal antibody ustekinumab is a novel Crohn's disease (CD) treatment blocking pro-inflammatory cytokines interleukin-12 and 23. The study's objective was to assess cost-effectiveness of ustekinumab in moderate to...